Nantahala Capital Management’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,251,139
| Closed | -$827K | – | 127 |
|
|
2023
Q2 | $827K | Sell |
1,251,139
-471,261
| -27% | -$312K | 0.08% | 84 |
|
|
2023
Q1 | $1.35M | Sell |
1,722,400
-1,277,365
| -43% | -$1M | 0.1% | 78 |
|
|
2022
Q4 | $6.78M | Buy |
2,999,765
+1,388,943
| +86% | +$3.14M | 0.44% | 38 |
|
|
2022
Q3 | $3.25M | Sell |
1,610,822
-32,616
| -2% | -$65.7K | 0.21% | 48 |
|
|
2022
Q2 | $6.11M | Buy |
1,643,438
+309,491
| +23% | +$1.15M | 0.31% | 43 |
|
|
2022
Q1 | $8.7M | Sell |
1,333,947
-122,200
| -8% | -$797K | 0.38% | 38 |
|
|
2021
Q4 | $17M | Buy |
1,456,147
+206,838
| +17% | +$2.41M | 0.6% | 27 |
|
|
2021
Q3 | $23.3M | Buy |
1,249,309
+817,237
| +189% | +$15.2M | 0.73% | 23 |
|
|
2021
Q2 | $9.16M | Buy |
432,072
+395,116
| +1,069% | +$8.38M | 0.26% | 59 |
|
|
2021
Q1 | $750K | Sell |
36,956
-41,620
| -53% | -$845K | 0.02% | 93 |
|
|
2020
Q4 | $2.09M | Buy |
78,576
+3,576
| +5% | +$94.9K | 0.06% | 89 |
|
|
2020
Q3 | $1.68M | Buy |
+75,000
| New | +$1.68M | 0.05% | 88 |
|